COVID-19

Responses of patients with cancer to mRNA vaccines depend on the time interval between vaccination and last treatment
Lara Victoria Donhauser, Julia Veloso de Oliveira, Cordula Schick, Wenzel Manlik, Sabrina Styblova, Sarah Lutzenberger, Michael Aigner, Patrick Philipp, Sebastian Robert, Beate Gandorfer, Dirk Hempel, Louisa Hempel, Dietmar Zehn

Journal for ImmunoTherapy of Cancer Sep 2023, 11 (9) e007387; DOI: 10.1136/jitc-2023-007387
COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Juan Ignacio Ruiz, Maria Angeles Lopez-Olivo, Yimin Geng, Maria E Suarez-Almazor

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006246; DOI: 10.1136/jitc-2022-006246
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano, Amy Moskop, Adriana Balduzzi, Jennifer Krajewski, Hema Dave, Anant Vatsayan, Colleen Callahan, Hongyan Liu, Yimei Li, Kara Lynn Davis, Shannon L Maude

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005957; DOI: 10.1136/jitc-2022-005957
Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy
Simon Deycmar, Bruno Gomes, Jehad Charo, Maurizio Ceppi, J Mark Cline

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005514; DOI: 10.1136/jitc-2022-005514
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
Alessio Cortellini, Gino M Dettorre, Urania Dafni, Juan Aguilar-Company, Luis Castelo-Branco, Matteo Lambertini, Spyridon Gennatas, Vasileios Angelis, Ailsa Sita-Lumsden, Jacobo Rogado, Paolo Pedrazzoli, David Viñal, Aleix Prat, Maura Rossi, Rossana Berardi, Teresa Alonso-Gordoa, Salvatore Grisanti, Georgia Dimopoulou, Paola Queirolo, Sylvain Pradervand, Alexia Bertuzzi, Mark Bower, Dirk Arnold, Ramon Salazar, Marco Tucci, Kevin J Harrington, Francesca Mazzoni, Uma Mukherjee, Zoi Tsourti, Olivier Michielin, Fanny Pommeret, Joan Brunet, Bruno Vincenzi, Giuseppe Tonini, Andrea Patriarca, Federica Biello, Marco Krengli, Josep Tabernero, George Pentheroudakis, Alessandra Gennari, Solange Peters, Emanuela Romano, David J Pinato

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005732; DOI: 10.1136/jitc-2022-005732
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine
Djordje Atanackovic, Robert J Kreitman, Jeffrey Cohen, Nancy M Hardy, Destiny Omili, Thierry Iraguha, Peter D Burbelo, Etse Gebru, Xiaoxuan Fan, John Baddley, Tim Luetkens, Saurabh Dahiya, Aaron P Rapoport

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004953; DOI: 10.1136/jitc-2022-004953
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
Sherin Juliet Rouhani, Jovian Yu, Daniel Olson, Yuanyuan Zha, Apameh Pezeshk, Alexandra Cabanov, Athalia R Pyzer, Jonathan Trujillo, Benjamin A Derman, Peter O'Donnell, Andrzej Jakubowiak, Hedy L Kindler, Christine Bestvina, Thomas F Gajewski

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004766; DOI: 10.1136/jitc-2022-004766
JAK inhibitors and COVID-19
Gabriel Levy, Paola Guglielmelli, Peter Langmuir, Stefan N Constantinescu

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e002838; DOI: 10.1136/jitc-2021-002838
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis
Yifei Ma, Nianqi Liu, Youlong Wang, Jiling Zeng, Ying-Ying Hu, Wu Hao, Huazheng Shi, Pengfei Zhu, Jun Lv, Wei Fan, Xinjia Wang

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003712; DOI: 10.1136/jitc-2021-003712
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
Benjamin Switzer, John Haanen, Paul C Lorigan, Igor Puzanov, Samra Turajlic

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002835; DOI: 10.1136/jitc-2021-002835

Main menu

COVID-19

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

COVID-19

Pages